Q32 Bio Inc. · NASDAQ:QTTB

Orbimed Advisors LLC reported a 17.40% stake in Q32 Bio Inc. (Schedule 13D/A)

Event May 28, 2026 · Filed Jun 1, 2026

Orbimed Advisors LLC reported a 17.40% stake in Q32 Bio Inc., 4,127,987 shares, with active intent on May 28, 2026. Filed Jun 1, 2026 (Schedule 13D/A).

Stake
17.40%
Shares
4,127,987
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC17.40%4,127,987
ORBIMED CAPITAL GP VII LLC14.80%3,502,987
OrbiMed Genesis GP LLC2.60%625,000

Source

View original at SEC

Related